| Literature DB >> 28067813 |
Fabio Tramuto1,2, Emanuele Amodio3, Giuseppe Calamusa4, Vincenzo Restivo5, Claudio Costantino6, Francesco Vitale7,8.
Abstract
The spread of Streptococcus pneumoniae within families has been scarcely investigated so far. This feasibility study aimed to estimate the prevalence of pneumococcal carriage in school-aged children and co-habiting relatives and to explore the potential link between the family environment and the sharing of pneumococcal serotypes covered by the vaccine. Oropharyngeal samples of 146 subjects belonging to 36 different family groups were molecularly tested for pneumococcal detection and serotyping. The overall prevalence of pneumococcal carriage was 65.8% (n = 96/146), whereas it was higher among schoolchildren (77.8%, n = 28/36); subjects of seven years of age had the highest odds of being colonized (odds ratio, OR = 5.176; p = 0.145). Pneumococcal serotypes included in the 13-valent conjugate vaccine formulation were largely detected in the study population and multiple serotypes colonization was considerable. Factors relating to a close proximity among people at the family level were statistically associated with pneumococcal carriage (OR = 2.121; p = 0.049), as well as active smoking habit with a clear dose-response effect (ORs = 1.017-3.326). About half of family clusters evidenced similar patterns of carried pneumococcal serotypes and the odds of sustaining a high level of intrafamilial sharing increased with household size (ORs = 1.083-5.000). This study highlighted the potential role played by the family environment in sustaining both the circulation and horizontal transmission of pneumococcus.Entities:
Keywords: Streptococcus pneumoniae; carriage; colonization; conjugate vaccine; family; horizontal transmission; real-time PCR; schoolchildren; serotypes
Mesh:
Substances:
Year: 2017 PMID: 28067813 PMCID: PMC5297739 DOI: 10.3390/ijms18010105
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Demographics, clinical characteristics and vaccination status of study participants.
| Study Population | Total | School Children | Family Members | |
|---|---|---|---|---|
| <12 Years | ≥12 Years | |||
| 146 | 36 (24.7) | 18 (12.3) | 92 (63.0) | |
| 31.0 (36.0) | 7 (2.0) | 5 (8.0) | 39.0 (23.0) | |
| Age-group (years) | ||||
| 5–6 | 22 (15.1) | 12 (33.3) | 10 (55.6) | 0 |
| 7 | 9 (6.2) | 8 (22.2) | 1 (5.5) | 0 |
| 8–11 | 23 (15.7) | 16 (44.5) | 7 (38.9) | 0 |
| 12–25 (teenagers/young adults) | 12 (8.2) | 0 | 0 | 12 (13.1) |
| 26–49 (adults) | 52 (35.6) | 0 | 0 | 52 (56.5) |
| ≥50 (older adults/elderly) | 28 (19.2) | 0 | 0 | 28 (30.4) |
| Male | 64 (43.8) | 23 (63.9) | 10 (55.6) | 31 (33.7) |
| Female | 82 (56.2) | 13 (36.1) | 8 (44.4) | 61 (63.3) |
| None | 58 (63.0) | 58 (63.0) | ||
| Employed | 34 (37.0) | 34 (37.0) | ||
| None | 10 (10.9) | 10 (10.9) | ||
| Primary education | 15 (16.3) | 15 (16.3) | ||
| Lower secondary education | 40 (43.5) | 40 (43.5) | ||
| Upper secondary education | 23 (25.0) | 23 (25.0) | ||
| Academic degree | 4 (4.3) | 4 (4.3) | ||
| Non-smokers | 48 (52.2) | 48 (52.2) | ||
| Passive smokers ( | 16 (33.3) | 16 (33.3) | ||
| Active smokers | 44 (47.8) | 44 (47.8) | ||
| Age of starting smoking (year; median (IQR)) | 15 (4.5) | 15 (4.5) | ||
| Number of cigarettes/cigars ( | 15 (45) | 15 (45) | ||
| Hours/week ( | 3 (3) | 2 (1) | 2 (1) | 5 (6) |
| Yes | 23 (15.7) | 8 (22.2) | 4 (22.2) | 11 (12.0) |
| Pre-existing diseases | 78 (53.4) | 8 (22.2) | 2 (11.1) | 68 (73.9) |
| Diabetes | 2 (2.6) | 0 | 0 | 2 (2.9) |
| Hypertension | 22 (28.2) | 0 | 0 | 22 (32.4) |
| Heart diseases | 5 (6.4) | 0 | 0 | 5 (7.3) |
| Chronic bronchitis/emphysema | 8 (10.2) | 0 | 0 | 8 (11.8) |
| Other | 41 (52.6) | 8 (100.0) # | 2 (100.0) # | 31 (45.6) |
| Pneumococcal | 46 (31.5) | 31 (86.1) ∆ | 13 (72.2) ∆∆ | 2 (2.2) ∆∆∆ |
| Complete vaccination schedule ( | 41 (89.1) | 30 (96.8) | 10 (76.9) | 1 (50.0) |
| Hexavalent | 55 (38.7) | 34 (94.4) | 18 (100.0) | 3 (3.3) |
| MMR | 54 (37.0) | 33 (91.7) | 18 (100.0) | 3 (3.3) |
| Varicella | 47 (32.2) | 29 (80.6) | 15 (83.3) | 3 (3.3) |
| Meningococcal C | 13 (8.9) | 5 (13.9) | 7 (38.9) | 1 (1.1) |
| Influenza (last 12 months) | 8 (5.5) | 1 (2.8) | 0 | 7 (7.6) |
IQR: interquartile range; Hexavalent: diphtheria, tetanus, acellular pertussis, Haemophilus influenzae type B, poliovirus, and hepatitis B; MMR: measles, mumps, and rubella; # 50%, with allergy-related diseases; ∆ 7-valent pneumococcal conjugate vaccine (PCV7): 24 subjects; PCV7 + PCV13: 7 subjects; ∆∆ PCV7: 5 subjects; PCV7 + PCV13: 3 subjects; PCV13: 5 subjects; ∆∆∆ PCV7: 1 subjects; PPV23: 1 subjects.
Main socio-demographic characteristics and vaccination status of the study population, according to pneumococcal colonization (lytA-pos vs. lytA-neg).
| Study Population | Pneumococcal Colonization ( | Odds Ratio (95% CI) | ||
|---|---|---|---|---|
| No | Yes | |||
| Study participants ( | 50 (34.2) | 96 (65.8) | ||
| Schoolchildren | 8 (22.2) | 28 (77.8) | 0.084 | 2.161 (0.901–5.185) |
| Family members | 42 (38.2) | 68 (61.8) | (reference) | |
| 5–6 | 8 (36.4) | 14 (63.6) | 0.833 | 1.132 (0.357–3.587) |
| 7 | 1 (11.1) | 8 (88.9) | 0.145 | 5.176 (0.566–47.323) |
| 8–11 | 5 (21.7) | 18 (78.3) | 0.184 | 2.329 (0.669–8.112) |
| 12–25 | 2 (16.7) | 10 (83.3) | 0.175 | 3.235 (0.593–17.658) |
| 26–49 | 23 (44.2) | 29 (55.8) | 0.670 | 0.816 (0.320–2.079) |
| ≥50 | 11 (39.3) | 17 (60.7) | (reference) | |
| Male | 23 (35.9) | 41 (64.1) | (reference) | |
| Female | 27 (32.9) | 55 (67.1) | 0.704 | 1.143 (0.574–2.273) |
| Low | 37 (40.2) | 55 (59.8) | (reference) | |
| High | 13 (24.1) | 41 (75.9) | 0.049 | 2.121 (1.002–4.492) |
| Non-smokers | 23 (46.0) | 27 (54.0) | (reference) | |
| Active smokers | 13 (30.9) | 29 (69.1) | 0.143 | 1.900 (0.805–4.484) |
| Number of cigarettes/cigars per day | ||||
| <5 cigarettes/day | 22 (39.3) | 34 (60.7) | (reference) | |
| ≥5 cigarettes/day | 14 (38.9) | 22 (61.1) | 0.970 | 1.017 (0.431–2.399) |
| <10 cigarettes/day | 28 (44.4) | 35 (55.6) | (reference) | |
| ≥10 cigarettes/day | 8 (27.6) | 21 (72.4) | 0.127 | 2.100 (0.809–5.451) |
| <15 cigarettes/day | 32 (43.8) | 41 (56.2) | (reference) | |
| ≥15 cigarettes/day | 4 (21.0) | 15 (79.0) | 0.078 | 2.927 (0.885–9.678) |
| <20 cigarettes/day | 33 (43.4) | 43 (56.6) | (reference) | |
| ≥20 cigarettes/day | 3 (18.8) | 13 (81.2) | 0.078 | 3.326 (0.875–12.634) |
| Yes | 9 (39.1) | 14 (60.9) | (reference) | |
| No | 41 (33.3) | 82 (66.7) | 0.591 | 1.286 (0.514–3.218) |
| No | 30 (38.5) | 48 (61.5) | (reference) | |
| Yes | 20 (29.4) | 48 (70.6) | 0.251 | 1.500 (0.750–2.999) |
Crowding index—“High” identifies families consisting of three persons or more and living in a dwelling with four rooms or less; Respiratory co-morbidities—At least one of the following disease: asthma, chronic bronchitis, nasal obstruction, allergic rhinitis, sinusitis, otitis, tonsillectomy, adenoidectomy.
Figure 1Relative proportions of concurrent PCV13 serotypes identified in oropharyngeal swab specimens collected from healthy subjects positive for Streptococcus pneumoniae (co-colonization).
Figure 2Distribution of PCV13 serotype (in ranking order) of colonizing pneumococcal strains collected from schoolchildren and household contacts. Bar graphs indicate the percentage of each serotype determined in relation to the total number of identified serotypes in the study period. Labels including the character “/” identify potential cross-reacting molecular targets.
Intrafamilial sharing of pneumococcal serotypes, expressed as percentage of detected serotypes in common between household contacts and student, selected as reference.
| ID Family Number | Student Age (Reference Case) | Household Size | Intrafamilial Sharing (%) |
|---|---|---|---|
| 14 | 8 | 2 | 100.0 |
| 23 | 9 | 5 | 90.9 |
| 2 | 8 | 5 | 90.5 |
| 11 | 6 | 4 | 84.6 |
| 34 | 7 | 7 | 81.2 |
| 12 | 8 | 3 | 75.0 |
| 25 | 6 | 3 | 75.0 |
| 33 | 9 | 2 | 75.0 |
| 16 | 7 | 7 | 71.4 |
| 3 | 9 | 5 | 70.8 |
| 20 | 8 | 3 | 69.2 |
| 6 | 8 | 4 | 68.7 |
| 28 | 11 | 4 | 68.7 |
| 19 | 8 | 9 | 65.2 |
| 26 | 7 | 3 | 60.0 |
| 27 | 6 | 5 | 50.0 |
| 10 | 7 | 5 | 47.0 |
| 30 | 8 | 4 | 46.7 |
| 5 | 7 | 3 | 44.4 |
| 21 | 6 | 5 | 42.9 |
| 17 | 8 | 4 | 25.0 |
| 31 | 7 | 4 | 18.2 |
| 1 | 8 | 5 | 0 |
| 4 | 6 | 2 | 0 |
| 7 | 6 | 4 | 0 |
| 8 | 6 | 3 | 0 |
| 9 | 7 | 3 | 0 |
| 13 | 7 | 4 | 0 |
| 15 | 6 | 6 | 0 |
| 18 | 6 | 3 | 0 |
| 22 | 8 | 1 | 0 |
| 24 | 8 | 5 | 0 |
| 29 | 6 | 3 | 0 |
| 32 | 8 | 5 | 0 |
| 35 | 6 | 2 | 0 |
| 36 | 6 | 4 | 0 |
Socio-demographic variables and pneumococcal intrafamilial sharing, according to low (≤50%) and high score (>50%).
| Intrafamilial Sharing | Odds Ratio (95% CI) | |||
|---|---|---|---|---|
| Low | High | |||
| Low | 15 (62.5) | 9 (37.5) | (reference) | |
| High | 6 (50.0) | 6 (50.0) | 0.475 | 1.667 (0.410–6.767) |
| ≤2 persons | 3 (60.0) | 2 (40.0) | (reference) | |
| >2 persons | 18 (58.1) | 13 (41.9) | 0.935 | 1.083 (0.158–7.435) |
| ≤3 persons | 9 (60.0) | 6 (40.0) | (reference) | |
| >3 persons | 12 (57.1) | 9 (42.9) | 0.864 | 1.125 (0.292–4.326) |
| ≤4 persons | 15 (65.2) | 8 (34.8) | (reference) | |
| >4 persons | 6 (46.1) | 7 (53.9) | 0.269 | 2.188 (0.546–8.761) |
| ≤5 persons | 20 (62.5) | 12 (37.5) | (reference) | |
| >5 persons | 1 (25.0) | 3 (75.0) | 0.184 | 5.000 (0.466–53.682) |
Crowding index: “High” identifies families consisting of three persons or more and living in a dwelling with four rooms or less.